Canadian Institutes of Health Research

Look at the Science

Female grant applicants do about as well as their male colleagues when the review focuses on the science proposed, according to Nature News.

Canadian Rare Diseases Models and Mechanisms network receives C$2.3 million to support model organism research

NEW YORK (GenomeWeb) – Four Canadian government research funding agencies will spend around C$7.3 million (US$6.7 million) to create a cloud computing facility and data mining tools that will enable researchers to access and use data from the International Cancer Genome Consortium.

NEW YORK (GenomeWeb News) – The Canadian Institutes of Health Research and Genome Canada plan to provide C$2.3 million (US$2.2 million) to fund a national network to help clinical researchers studying genes involved in rare diseases to partner with experts in model organisms, CIHR said yesterday.

NEW YORK (GenomeWeb News) – Canada's government has awarded C$10 million (US$9.7 million) to fund a research program at McGill University focused on pain genetics that will be headed by Luda Diatchenko, McGill said yesterday.

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

NEW YORK (GenomeWeb News) – Genome Canada and the Canadian Institutes of Health Research said today that a number of new genomics and personalized medicine research projects focused on tackling common, complex, and rare diseases have received C$150 million (US$147.5 million) in new grants.

NEW YORK (GenomeWeb News) – The Canadian government has invested C$19 million (US$19.3 million) in new collaborative research projects to develop a range of biomedical technologies including tools to advance microfluidics, mass spectrometry, and drug screening.

NEW YORK (GenomeWeb News) – Genome Canada and the Canadian Institute of Health Research will award C$6.3 million (US$6.1 million) to research projects under its 2012 Bioinformatics and Computational Biology Competition to develop new tools to deal with the large volumes of data being generated fr

The device, named the Verisante Aura, uses Raman spectroscopy to measure levels of various biomarkers – including proteins, nucleic acids, and metabolites – in skin lesions. In initial clinical trials it distinguished between benign and malignant lesions with 100-percent sensitivity and 70-percent specificity.

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.